Characteristics | N | % (95% CI) | p |
---|---|---|---|
Age (years) | < 0.001 | ||
0–5 | 172 | 36.3 (32.0–40.8) | |
6–14 | 124 | 26.2 (22.3–30.4) | |
15–49 | 154 | 32.5 (28.3–36.9) | |
50–76 | 24 | 5.1 (3.3–7.5) | |
Total | 474 | 100.0 | |
Sex | < 0.001 | ||
Female | 272 | 57.4 (52.8–61.9) | |
Male | 202 | 42.6 (38.1–47.2) | |
Total | 474 | 100.0 | |
Anti-malarial used for initial episode | 0.009 | ||
ASAQ | 196 | 41.4 (36.9–45.9) | |
AL | 273 | 57.6 (53.0–62.1) | |
DP | 5 | 1.1 (0.3–2.4) | |
Total | 474 | 100.0 | |
Enrolled patients per site | < 0.001 | ||
Bolenge | 88 | 18.6 (15.2–22.4) | |
Fungurume | 83 | 17.5 (14.2–21.2) | |
Kabondo | 20 | 4.2 (2.6–6.4) | |
Katana | 143 | 30.2 (26.1–34.5) | |
Kingasani | 113 | 23.8 (20.1–27.9) | |
Vanga | 27 | 5.7 (3.8–8.2) | |
Total | 474 | 100.0 | |
Detection of P. falciparum by PCR | < 0.001 | ||
Negative | 110 | 23.2 (19.5–27.3) | |
Positive | 364 | 76.8 (72.7–80.5) | |
Total | 474 | 100.0 |